康泰生物 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	2.7B	3.5B	3.2B	3.7B	2.3B
Revenue Growth %	-23.7%	10.1%	-13.6%	61.5%	--
Total Revenue	2.7B	3.5B	3.2B	3.7B	2.3B
Cost Of Revenue	477.0M	538.0M	500.0M	986.0M	226.0M
+Gross Profit	2.2B	2.9B	2.7B	2.7B	2.0B
Gross Margin %	82.0%	84.5%	84.2%	73.0%	90.0%
Total Operating Cost	2.6B	2.7B	3.6B	2.3B	1.6B
Selling Expenses	887.0M	1.2B	1.1B	578.0M	878.0M
Admin Expenses	372.0M	276.0M	230.0M	253.0M	168.0M
Rd Expenses	508.0M	501.0M	802.0M	354.0M	267.0M
Finance Expenses	26.0M	-1.6M	-21.2M	-59.2M	-21.4M
+Operating Income	181.0M	949.0M	-318.0M	1.5B	775.0M
Operating Margin %	6.8%	27.3%	-10.1%	39.8%	34.3%
Non Operating Income	4.2M	1.0M	6.6M	1.8M	5.3M
Non Operating Expenses	35.5M	9.6M	27.3M	14.8M	8.3M
Investment Income	465,000	1.7M	944,000	29.7M	13.7M
Fair Value Change Income	1.4M	192,200	3.2M	--	30.1M
Asset Disposal Income	-8.4M	-1.3M	127,400	27,100	-291,900
Asset Impairment Loss	232.0M	119.0M	896.0M	155.0M	4.2M
Other Income	98.5M	172.0M	74.4M	68.9M	28.6M
Income Before Tax	150.0M	940.0M	-338.0M	1.4B	772.0M
Income Tax	-51.6M	79.0M	-206.0M	176.0M	93.2M
+Net Income	202.0M	861.0M	-133.0M	1.3B	679.0M
Net Margin %	7.6%	24.8%	-4.2%	34.6%	30.0%
Net Income Attributable	202.0M	861.0M	-133.0M	1.3B	679.0M
Minority Interest	-98,600	--	--	--	--
Eps Basic	0.18	0.77	-0.12	1.85	1.03
Eps Diluted	0.18	0.77	-0.12	1.82	1.01

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	433.0M	1.2B	1.0B	3.5B	883.0M
Trading Financial Assets	--	100.0M	441.0M	--	2.2B
Accounts Receivable	2.8B	2.8B	2.3B	1.5B	1.6B
Notes Receivable	--	--	--	398.0M	--
Notes And Accounts Receivable	2.8B	2.8B	2.3B	1.9B	1.6B
Prepayments	26.6M	44.7M	110.0M	119.0M	93.3M
Inventory	783.0M	773.0M	728.0M	1.1B	437.0M
Total Current Assets	6.2B	5.4B	5.2B	7.3B	5.3B
Fixed Assets	--	3.4B	1.7B	1.8B	1.1B
Fixed Assets Total	4.2B	3.4B	1.7B	1.8B	1.1B
Construction In Progress	--	2.3B	3.5B	2.3B	1.1B
Construction In Progress Total	990.0M	2.3B	3.5B	2.3B	1.1B
Intangible Assets	437.0M	433.0M	358.0M	346.0M	294.0M
Long Term Deferred Expenses	170.0M	102.0M	78.8M	99.4M	123.0M
Total Non Current Assets	8.3B	9.7B	8.6B	6.8B	4.2B
Total Assets	14.6B	15.1B	13.8B	14.1B	9.6B
Short Term Borrowings	34.1M	60.0M	170.0M	778.0M	11.3M
Accounts Payable	661.0M	791.0M	320.0M	708.0M	160.0M
Advance Receipts	858,900	409,300	--	--	--
Contract Liabilities	18.4M	28.3M	31.2M	94.5M	14.9M
Total Current Liabilities	2.6B	2.8B	2.3B	2.6B	1.8B
Long Term Borrowings	--	671.0M	405.0M	418.0M	67.8M
Total Non Current Liabilities	2.3B	2.8B	2.5B	2.4B	365.0M
Total Liabilities	4.9B	5.5B	4.8B	5.0B	2.1B
Paid In Capital	1.1B	1.1B	1.1B	687.0M	685.0M
Capital Reserve	5.5B	5.4B	5.5B	5.4B	5.3B
Surplus Reserve	347.0M	328.0M	243.0M	177.0M	157.0M
Retained Earnings	2.2B	2.2B	1.6B	2.4B	1.4B
Minority Equity	-98,600	--	--	--	--
Equity Attributable	9.7B	9.5B	9.0B	9.2B	7.5B
Total Equity	9.7B	9.5B	9.0B	9.2B	7.5B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	2.8B	3.1B	2.7B	3.6B	1.7B
Tax Refunds Received	--	12.6M	10.8M	12.9M	3.5M
Total Operating Cash Inflow	2.9B	3.4B	3.1B	3.9B	2.0B
Cash Paid For Goods	370.0M	333.0M	743.0M	932.0M	373.0M
Cash Paid To Employees	534.0M	515.0M	516.0M	444.0M	261.0M
Taxes Paid	123.0M	98.3M	196.0M	51.6M	153.0M
Total Operating Cash Outflow	2.3B	2.3B	2.5B	2.2B	1.5B
Operating Cash Flow	603.0M	1.0B	546.0M	1.7B	440.0M
Total Investing Cash Inflow	863.0M	1.1B	2.2B	2.2B	14.7M
Total Investing Cash Outflow	1.4B	1.5B	4.8B	3.6B	3.9B
Investing Cash Flow	-557.0M	-439.0M	-2.6B	-1.4B	-3.8B
Cash From Borrowings	213.0M	380.0M	529.0M	3.1B	91.1M
Dividends And Interest Paid	257.0M	237.0M	622.0M	220.0M	207.0M
Debt Repayments	743.0M	299.0M	1.1B	26.5M	256.0M
Total Financing Cash Inflow	224.0M	381.0M	1.3B	3.4B	4.2B
Total Financing Cash Outflow	1.0B	799.0M	1.7B	939.0M	465.0M
Financing Cash Flow	-801.0M	-418.0M	-465.0M	2.5B	3.8B
Net Change In Cash	-754.0M	176.0M	-2.5B	2.7B	382.0M
Ending Cash Balance	416.0M	1.2B	994.0M	3.5B	858.0M
Capex	472.0M	718.0M	1.3B	2.5B	1.2B